Baker Department of Cardiometabolic Health Research
Atherothrombosis and Vascular Biology Group
Research Program Leader: Professor Karlheinz Peter
The Atherothrombosis and Vascular Biology Group is developing advanced biotechnological tools for molecular imaging and innovative therapy of atherosclerosis, thrombosis and inflammation.
Cardiac Hypertrophy Group
Research Program Leader : Associate Professor Julie McMullen
The Cardiac Hypertrophy Group is focused on better understanding heart enlargement through comparing models of health and disease.
Haematopoesis and Leukocyte Biology Group
Research Program Leader : Associate Professor Andrew Murphy
The goal of the Haematopoesis and Leukocyte Biology Research Group is to understand the pathways contributing to enhanced leukocyte production and altered function in the context of chronic diseases.
Lipid Metabolism and Cardiometabolic Disease Group
Research Program Leader : Associate Professor Anna Calkin
The Lipid Metabolism and Cardiometabolic Disease Group takes a systems genetics approach to unravel the mechanistic underpinnings of cardiometabolic disease. and identify novel therapeutic targets.Metabolomics Group
Research Program Leader: Professor Peter Meikle
The goal of the Metabolomics Group is defining the relationships between lipid metabolism and cardiometabolic disease to advance diagnosis and treatment.
Molecular Imaging and Theranostics Group
Research Program Leader: Dr Xiaowei Wang
The Molecular Imaging and Theranostics Group is working towards more sensitive diagnosis using molecular imaging, targeted therapies free from side-effects and using novel theranostic approaches for cardiovascular diseases.
Molecular Metabolism and Ageing Group
Research Program Leader: Associate Professor Brian Drew
The goal of the Molecular Metabolism and Ageing Group is to identify the genetic and molecular underpinnings of cardiometabolic disorders and ageing, with the ultimate aim of manipulating these pathways for therapeutic benefit.